UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029865
Receipt number R000034111
Scientific Title Postoperative Pain Management with Continuous Wound Infiltration in Patients undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis
Date of disclosure of the study information 2018/03/01
Last modified on 2018/01/31 19:58:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Postoperative Pain Management with Continuous Wound Infiltration in Patients undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis

Acronym

Postoperative Pain Management with Continuous Wound Infiltration in Patients undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis

Scientific Title

Postoperative Pain Management with Continuous Wound Infiltration in Patients undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis

Scientific Title:Acronym

Postoperative Pain Management with Continuous Wound Infiltration in Patients undergoing Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis

Region

Japan


Condition

Condition

Adolescent idiopathic scoliosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this clinical trial is to determine whether continuous wound infiltration of local anesthetics reduces postoperative pain in patients undergoing posterior spinal fusion for adolescent idiopathic scoliosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cumulative morphine consumption within 48h after surgery.

Key secondary outcomes

Pain scores (Numerical Rating Scale, 0-10), sedation scales, incidence of postoperative nausea and vomiting, antiemetic consumption and incidence of pruritus in the 48h after surgery.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation


Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Continuous wound infiltration of local anesthetic (48h)

Interventions/Control_2

No interventions

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

20 years-old >

Gender

Male and Female

Key inclusion criteria

Patients (equal to or older than 10 years old and younger than 20 years old) undergoing posterior spinal fusion for adolescent idiopathic scoliosis

Key exclusion criteria

Patients who are contraindicated to any study medications, who cannot answer the questionnaire and patients that the physician deems inappropriate.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Morisaki

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code


Address

35 Shinanomachi, Shinjukuku Tokyo, Japan

TEL

03-3353-1211

Email

morisaki@z8.keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Seki

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code


Address

35 Shinanomachi Shinjukuku, Tokyo Japan

TEL

03-3353-1211

Homepage URL


Email

hseki@a3.keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding (Department of Anesthesiology, Keio University School of Medicine)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 12 Month 25 Day

Date of IRB


Anticipated trial start date

2018 Year 03 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 07 Day

Last modified on

2018 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034111